Daiichi Sankyo (OTCMKTS:DSNKY) Updates FY 2026 Earnings Guidance

Daiichi Sankyo (OTCMKTS:DSNKY) issued an update on its FY 2026 earnings guidance on Monday morning. The company provided EPS guidance of 0.910-0.910 for the period, compared to the consensus EPS estimate of 1.040. The company issued revenue guidance of $14.5 billion-$14.5 billion, compared to the consensus revenue estimate of $13.4 billion.

Daiichi Sankyo Trading Up 1.8%

Shares of Daiichi Sankyo stock traded up $0.29 during trading hours on Monday, hitting $16.80. The company’s stock had a trading volume of 32,410 shares, compared to its average volume of 444,342. Daiichi Sankyo has a 12 month low of $15.56 and a 12 month high of $28.21. The stock has a 50 day moving average of $17.94 and a 200 day moving average of $20.47. The company has a market capitalization of $31.83 billion, a PE ratio of 15.41, a price-to-earnings-growth ratio of 0.85 and a beta of -0.25. The company has a debt-to-equity ratio of 0.18, a current ratio of 2.69 and a quick ratio of 1.85.

Wall Street Analysts Forecast Growth

Separately, Zacks Research upgraded Daiichi Sankyo from a “strong sell” rating to a “hold” rating in a report on Tuesday, May 5th. One research analyst has rated the stock with a Strong Buy rating and one has issued a Hold rating to the company. According to MarketBeat.com, the company currently has an average rating of “Buy”.

Daiichi Sankyo Company Profile

Daiichi Sankyo Co, Ltd. is a global, research-driven pharmaceutical company headquartered in Tokyo, Japan. The company was formed through the merger of Daiichi Pharmaceutical and Sankyo in 2005 and focuses on the discovery, development, manufacturing and commercialization of prescription medicines. Its therapeutic priorities include oncology and cardiovascular disease, and it pursues a mix of small molecules, biologics and antibody‑drug conjugates in its development programs.

Daiichi Sankyo is known for building a development portfolio through both internal research and collaborative partnerships.